Evidence map›Paper›PMID 26262996›Full record

Trial reportRedox biology2015

Effects of N-acetylcysteine, oral glutathione (GSH) and a novel sublingual form of GSH on oxidative stress markers: A comparative crossover study.

Bernard Schmitt, Morgane Vicenzi, Catherine Garrel, Frédéric M Denis

Abstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Redox biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 105 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

105 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  19. Review
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bernard SchmittCentre d'Enseignement et de Recherche en Nutrition Humaine, Centre Hospitalier de Bretagne Sud, 5 Avenue De Choiseul, BP 12233, 56322 Lorient Cedex, France. Electronic address: schmitt.lorient@yahoo.fr.
Morgane VicenziLaboratoires Le Stum, 4 impasse de Kerhoas, 56260 Larmor Plage, France. Electronic address: innov@labo-lestum.com.
Catherine GarrelUnité de Biochimie Hormonale et Nutritionnelle, Département de Biochimie, Toxicologie et Pharmacologie, Institut de Biologie et de Pathologie, Centre Hospitalier Universitaire de Grenoble, CS10217, 38043 Grenoble, France. Electronic address: CGarrel@chu-grenoble.fr.
Frédéric M DenisLaboratoires Le Stum, 4 impasse de Kerhoas, 56260 Larmor Plage, France. Electronic address: infomed@labo-lestum.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glutathione (GSH) is critical to fight against oxidative stress. Its very low bioavailability limits the interest of a supplementation. The purpose of this study was to compare the bioavailability, the effect on oxidative stress markers and the safety of a new sublingual form of GSH with two commonly used dietary supplements, N-acetylcysteine (NAC) and oral GSH. The study was a three-week randomized crossover trial. 20 Volunteers with metabolic syndrome were enrolled. GSH levels and several oxidative stress markers were determined at different times during each 21-days period. Compared to oral GSH group, an increase of total and reduced GSH levels in plasma and a higher GSH/GSSG ratio (p=0.003) was observed in sublingual GSH group. After 3 weeks of administration, there was a significant increase of vitamin E level in plasma only in sublingual GSH group (0.83 µmol/g; p=0.04). Our results demonstrate the superiority of a new sublingual form of GSH over the oral GSH form and NAC in terms of GSH supplementation.

Indexed as

Dietary SupplementsAcetylcysteineAdministration, OralAntioxidantsBiological AvailabilityBiomarkersBlood PressureBody Mass IndexCholesterol, HDLCholesterol, LDLCross-Over StudiesFemaleGlutathioneHumansMaleMetabolic SyndromeAcetylcysteineAntioxidantsBiomarkersCholesterol, HDLCholesterol, LDLGlutathioneTabletsTriglyceridesVitamin EDietary supplementGlutathioneMetabolic syndromeN-acetyl cysteineNutraceuticalsOral bioavailabilityOxidative stressSublingual

Identifiers

PMID26262996
PMCPMC4536296

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.